Dosage and administration
The usual canine dosage administered intravenously is 1.5 - 2.0 g per Kg body weight given over a 30 minute period. This is approximately 3.4-4.5 mL/lb of body weight.
The usual canine dosage administered intravenously is 1.5 - 2.0 g per Kg body weight given over a 30 minute period. This is approximately 3.4-4.5 mL/lb of body weight.
Store at temperatures between 15°and 30°C (59°-86°F)
Mannitol Injection 20% is indicated for use as an osmotic diuretic in canine species. Mannitol is essentially inert metabolically. When given parenterally, it is freely filtered at the glomerulus which produces osmotic diuresis as more than 90% of the mannitol injected escapes reabsorption.
Mannitol USP...................................20 g
Water for Injection...........................q.s.
This solution contains 1098 m0smols/Liter
The usual canine dosage administered intravenously is 1.5 - 2.0 g per Kg body weight given over a 30 minute period. This is approximately 3.4-4.5 mL/lb of body weight.
Crystals of mannitol may form in a 20% saturated solution of mannitol. Dissolve the crystals by warming in hot water or autoclaving for 15 minutes. Cool to body temperature before administering. This is a single dose vial that contains no preservatives. Use entire contents when first opened.
Store at temperatures between 15°and 30°C (59°-86°F)
RMS 92-384
Made in the USA
Item No. 09061
NDC 59051-8061-5
Mannitol Injection 20%
Sterile Solution
NeogenVet
Net Contentes: 100 mL
Lot No.
Exp. Date:
Neogen
Manufactured by: Nova-Tech, Grand Island, NE 68801
Manufactured for: Neogen Corporation, Lexington, KY 40511
859-254-1221
animalsafety.neogen.com
L566-0518
FOR ANIMAL USE ONLY
Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian.
KEEP OUT OF REACH OF CHILDREN
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 59051-8061 | MANNITOL 20% (MANNITOL) INJECTION [NEOGEN CORPORATION] | 1 | Unmatched | 20191123_83deb341-d3b1-4417-98ee-b5ea850d86fa.zip |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 59051-8061 | 59051-8061-5 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| MANNITOL | 3OWL53L36A | ACTIB |
| WATER | 059QF0KO0R | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Aridol Bronchial Challenge Test Kit | MANNITOL | Methapharm, Inc. | 5387a4fb-b894-4cba-88a3-a947217d34da | 2026-04-23 | Boxed warning, Warnings, Adverse reactions | MANNITOL |
| Mannitol | MANNITOL | Hospira, Inc. | 8ad3145e-00e7-4412-b9a5-06f00f264f30 | 2026-04-21 | Warnings, Adverse reactions | MANNITOL |
| Mannitol | MANNITOL | ProPharma Distribution | 430669d7-9ad1-9a04-e063-6394a90ababb | 2025-11-07 | Warnings, Adverse reactions | MANNITOL |
| Mannitol | MANNITOL | ICU Medical Inc. | ba7bf864-8a4d-4262-8fd1-00174fa2f9d1 | 2025-10-24 | Warnings, Adverse reactions | MANNITOL |
| Osmitrol | MANNITOL | Baxter Healthcare Company | 0d914965-7001-45cb-ba51-d7c5964b05bc | 2025-08-26 | Warnings, Adverse reactions | MANNITOL |
| Mannitol | MANNITOL | Henry Schein, Inc. | e2444db1-9dfe-451f-a33c-9b00786464d2 | 2025-05-20 | Warnings, Adverse reactions | MANNITOL |
| MANNITOL | MANNITOL | HF Acquisition Co LLC, DBA HealthFirst | 999ce711-2d5b-0d7d-e053-2995a90a2689 | 2024-01-27 | Warnings, Adverse reactions | MANNITOL |
| Mannitol | MANNITOL | B. Braun Medical Inc. | d12cc802-b538-4065-a264-f474ff3b3043 | 2023-08-15 | Warnings, Adverse reactions | MANNITOL |
| Mannitol | MANNITOL | Fresenius Kabi USA, LLC | c395e13d-6ea1-4104-8b37-669cfb982f04 | 2023-03-16 | Warnings, Adverse reactions | MANNITOL |
Adverse event summaries are temporarily unavailable. Other product information remains available.